Insider txns (12m)
43
Stock / equity
CVRX CVRx, Inc.
- Company
- CVRx, Inc.
- Security
- Equity
- Size, estimated from filings
- Micro cap (under $300M)
- Insiders on record
- 16
- Latest trade on record
- August 13, 2026
CVRX (CVRx, Inc.) has 43 disclosed insider transactions from 15 insiders in the last 12 months (3 open-market buys, 12 sales, about $1.1M at reported prices) and 0 congressional trades from 0 members of Congress. The most recent disclosure was filed August 13, 2026.
Open-market buys / sales
3 / 12
Congress trades (12m)
0
Distinct filers (12m)
15
Share price
Price and chart by TradingView for CVRx, Inc.. US share prices here are delayed, not real-time. The trade records on this page come from government filings, not from this chart.
CVRX in charts
Who is trading this stock
Which people account for the buying and selling over the last 12 months?
BoughtSold
8 people account for the disclosed buying and selling in CVRX over the last 12 months; the most active is JOHNSON & JOHNSON with $637K.
Prices insiders traded at
What price did insiders buy and sell at? Each marker is one open-market trade at the share price reported on its Form 4.
▲ Bought▼ SoldAverage reported price that day
Insiders reported 15 open-market trades in CVRX since Nov 6, 2025, at prices from $2.55 to $10.21; the most recent was a purchase at $2.91 on Aug 13, 2026. These are the prices on the filings, not adjusted for stock splits, and not a market price series.
Insider holdings over time
Is an insider building or unwinding a position? Shares held directly after each filing.
JOHNSON & JOHNSONBinkowski Brent
JOHNSON & JOHNSON reported 4,040,861 shares held after the latest filing, against 4,050,898 at the first on record.
Insiders trading CVRX
Everyone who filed a Form 4 for this ticker, by number of rows on record. "Bought" and "sold" count open-market purchases (code P) and sales only; awards, option exercises and shares withheld for tax are in the row count but not in those two columns. Showing 15 of 16.
| Insider | Role | Rows | Bought | Sold | Value bought | Value sold | Latest |
|---|---|---|---|---|---|---|---|
| GLAXOSMITHKLINE PLC | Insider | 13 | 1 | 0 | $5.0M | — | July 2, 2021 |
| JOHNSON & JOHNSON | Insider | 6 | 0 | 6 | — | $637K | November 26, 2025 |
| Binkowski Brent | CHIEF OPERATING OFFICER | 4 | 1 | 1 | $76K | $3,338 | August 13, 2026 |
| Jain Mudit K. | Director | 4 | 2 | 0 | $300K | — | June 1, 2026 |
| Adamson Philip B. | Chief Medical Officer | 3 | 0 | 1 | — | $9,973 | March 2, 2026 |
| Hykes Kevin | PRES & CEO | 3 | 0 | 1 | — | $61K | March 2, 2026 |
| John Robert Allen | Chief Revenue Officer | 3 | 0 | 1 | — | $31K | March 2, 2026 |
| OASHEIM JARED | CHIEF FINANCIAL OFFICER | 3 | 0 | 1 | — | $14K | March 2, 2026 |
| VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | 3 | 0 | 1 | — | $10K | March 2, 2026 |
| Ballinger Kevin J. | Director | 2 | 0 | 0 | — | — | June 1, 2026 |
| DALE MICHAEL D | Director | 2 | 0 | 0 | — | — | June 1, 2026 |
| Hill, Mitch C. | Director | 2 | 0 | 0 | — | — | June 1, 2026 |
| Nielsen Kirk G. | Director | 2 | 0 | 0 | — | — | June 1, 2026 |
| SHADAN MARTHA | Director | 2 | 0 | 0 | — | — | June 1, 2026 |
| SLATTERY JOSEPH P | Director | 2 | 0 | 0 | — | — | June 1, 2026 |
What kind of transactions these are 4 Form 4 codes
| Code | Meaning | Rows | Shares | Value at reported prices |
|---|---|---|---|---|
| A | Grant or award | 28 | 1,262,169 | — |
| C | Conversion of a derivative | 12 | 13,331,791 | — |
| S | Open-market sale | 12 | 79,895 | $767K |
| P | Open-market purchase | 4 | 348,623 | $5.3M |
What each code means: Form 4 transaction codes.
Insider transactions
| Filer | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| Binkowski Brent | Sell S | August 12, 2026 | August 13, 2026 | 1d | 1,309 | $3 | $3,338 | 10b5-1 plan | Form 4 ↗ | |
| Binkowski Brent | Buy P | August 13, 2026 | August 13, 2026 | 0d | 26,223 | $3 | $76K | Form 4 ↗ | ||
| DALE MICHAEL D | Other A | June 1, 2026 | June 3, 2026 | 2d | 36,252 | — | — | derivative | Form 4 ↗ | |
| DALE MICHAEL D | Other A | June 1, 2026 | June 3, 2026 | 2d | 29,005 | — | — | Form 4 ↗ | ||
| SHADAN MARTHA | Other A | June 1, 2026 | June 3, 2026 | 2d | 11,182 | — | — | derivative | Form 4 ↗ | |
| SHADAN MARTHA | Other A | June 1, 2026 | June 3, 2026 | 2d | 8,720 | — | — | Form 4 ↗ | ||
| Ballinger Kevin J. | Other A | June 1, 2026 | June 3, 2026 | 2d | 11,182 | — | — | derivative | Form 4 ↗ | |
| Ballinger Kevin J. | Other A | June 1, 2026 | June 3, 2026 | 2d | 8,720 | — | — | Form 4 ↗ | ||
| Hill, Mitch C. | Other A | June 1, 2026 | June 3, 2026 | 2d | 11,182 | — | — | derivative | Form 4 ↗ | |
| Hill, Mitch C. | Other A | June 1, 2026 | June 3, 2026 | 2d | 8,720 | — | — | Form 4 ↗ | ||
| SLATTERY JOSEPH P | Other A | June 1, 2026 | June 3, 2026 | 2d | 11,182 | — | — | derivative | Form 4 ↗ | |
| SLATTERY JOSEPH P | Other A | June 1, 2026 | June 3, 2026 | 2d | 8,720 | — | — | Form 4 ↗ | ||
| Jain Mudit K. | Other A | June 1, 2026 | June 3, 2026 | 2d | 11,182 | — | — | derivative | Form 4 ↗ | |
| Jain Mudit K. | Other A | June 1, 2026 | June 3, 2026 | 2d | 8,720 | — | — | Form 4 ↗ | ||
| Nielsen Kirk G. | Other A | June 1, 2026 | June 3, 2026 | 2d | 11,182 | — | — | derivative | Form 4 ↗ | |
| Nielsen Kirk G. | Other A | June 1, 2026 | June 3, 2026 | 2d | 8,720 | — | — | Form 4 ↗ | ||
| Adamson Philip B. | Other A | February 27, 2026 | March 16, 2026 | 17d | 62,000 | — | — | late10b5-1 planderivative | Form 4 ↗ | |
| Adamson Philip B. | Sell S | March 2, 2026 | March 16, 2026 | 14d | 1,262 | $8 | $9,973 | late10b5-1 plan | Form 4 ↗ | |
| Adamson Philip B. | Other A | February 27, 2026 | March 16, 2026 | 17d | 41,000 | — | — | late10b5-1 plan | Form 4 ↗ | |
| Morrison Gregory | Other A | March 2, 2026 | March 4, 2026 | 2d | 154,500 | — | — | derivative | Form 4 ↗ | |
| Morrison Gregory | Other A | March 2, 2026 | March 4, 2026 | 2d | 34,000 | — | — | Form 4 ↗ | ||
| Hykes Kevin | Other A | February 27, 2026 | March 3, 2026 | 4d | 238,000 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| Hykes Kevin | Sell S | March 2, 2026 | March 3, 2026 | 1d | 7,763 | $8 | $61K | 10b5-1 plan | Form 4 ↗ | |
| Hykes Kevin | Other A | February 27, 2026 | March 3, 2026 | 4d | 159,000 | — | — | 10b5-1 plan | Form 4 ↗ | |
| VERRASTRO PAUL | Other A | February 27, 2026 | March 3, 2026 | 4d | 67,000 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| VERRASTRO PAUL | Sell S | March 2, 2026 | March 3, 2026 | 1d | 1,284 | $8 | $10K | 10b5-1 plan | Form 4 ↗ | |
| VERRASTRO PAUL | Other A | February 27, 2026 | March 3, 2026 | 4d | 45,000 | — | — | 10b5-1 plan | Form 4 ↗ | |
| OASHEIM JARED | Other A | February 27, 2026 | March 3, 2026 | 4d | 91,000 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| OASHEIM JARED | Sell S | March 2, 2026 | March 3, 2026 | 1d | 1,744 | $8 | $14K | 10b5-1 plan | Form 4 ↗ | |
| OASHEIM JARED | Other A | February 27, 2026 | March 3, 2026 | 4d | 61,000 | — | — | 10b5-1 plan | Form 4 ↗ | |
| John Robert Allen | Other A | February 27, 2026 | March 3, 2026 | 4d | 52,000 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| John Robert Allen | Sell S | March 2, 2026 | March 3, 2026 | 1d | 3,964 | $8 | $31K | 10b5-1 plan | Form 4 ↗ | |
| John Robert Allen | Other A | February 27, 2026 | March 3, 2026 | 4d | 35,000 | — | — | 10b5-1 plan | Form 4 ↗ | |
| Binkowski Brent | Other A | February 27, 2026 | March 3, 2026 | 4d | 23,000 | — | — | derivative | Form 4 ↗ | |
| Binkowski Brent | Other A | February 27, 2026 | March 3, 2026 | 4d | 15,000 | — | — | Form 4 ↗ | ||
| Jain Mudit K. | Buy P | February 20, 2026 | February 23, 2026 | 3d | 46,800 | $6 | $298K | indirect | Form 4 ↗ | |
| Jain Mudit K. | Buy P | February 18, 2026 | February 18, 2026 | 0d | 600 | $5 | $2,785 | Form 4 ↗ | ||
| JOHNSON & JOHNSON | Sell S | November 26, 2025 | December 1, 2025 | 5d | 6,337 | $10 | $64K | lateindirect | Form 4 ↗ | |
| JOHNSON & JOHNSON | Sell S | November 24, 2025 | November 25, 2025 | 1d | 2,200 | $10 | $22K | indirect | Form 4 ↗ | |
| JOHNSON & JOHNSON | Sell S | November 21, 2025 | November 25, 2025 | 4d | 500 | $10 | $5,000 | indirect | Form 4 ↗ | |
| JOHNSON & JOHNSON | Sell S | November 12, 2025 | November 14, 2025 | 2d | 1,000 | $10 | $10K | indirect | Form 4 ↗ | |
| JOHNSON & JOHNSON | Sell S | November 7, 2025 | November 10, 2025 | 3d | 200 | $10 | $2,000 | indirect | Form 4 ↗ | |
| JOHNSON & JOHNSON | Sell S | November 6, 2025 | November 10, 2025 | 4d | 52,332 | $10 | $534K | indirect | Form 4 ↗ | |
| GLAXOSMITHKLINE PLC | Exchange C | July 2, 2021 | July 6, 2021 | 4d | 10,055,408 | — | — | indirectderivative | Form 4 ↗ | |
| GLAXOSMITHKLINE PLC | Exchange C | July 2, 2021 | July 6, 2021 | 4d | 1,081,434 | — | — | indirectderivative | Form 4 ↗ | |
| GLAXOSMITHKLINE PLC | Exchange C | July 2, 2021 | July 6, 2021 | 4d | 331,399 | — | — | indirectderivative | Form 4 ↗ | |
| GLAXOSMITHKLINE PLC | Exchange C | July 2, 2021 | July 6, 2021 | 4d | 589,939 | — | — | indirectderivative | Form 4 ↗ | |
| GLAXOSMITHKLINE PLC | Exchange C | July 2, 2021 | July 6, 2021 | 4d | 513,312 | — | — | indirectderivative | Form 4 ↗ | |
| GLAXOSMITHKLINE PLC | Exchange C | July 2, 2021 | July 6, 2021 | 4d | 59,527 | — | — | indirectderivative | Form 4 ↗ | |
| GLAXOSMITHKLINE PLC | Buy P | July 2, 2021 | July 6, 2021 | 4d | 275,000 | $18 | $5.0M | indirect | Form 4 ↗ | |
| GLAXOSMITHKLINE PLC | Exchange C | July 2, 2021 | July 6, 2021 | 4d | 635,646 | — | — | indirect | Form 4 ↗ | |
| GLAXOSMITHKLINE PLC | Exchange C | July 2, 2021 | July 6, 2021 | 4d | 27,345 | — | — | indirect | Form 4 ↗ | |
| GLAXOSMITHKLINE PLC | Exchange C | July 2, 2021 | July 6, 2021 | 4d | 8,380 | — | — | indirect | Form 4 ↗ | |
| GLAXOSMITHKLINE PLC | Exchange C | July 2, 2021 | July 6, 2021 | 4d | 14,917 | — | — | indirect | Form 4 ↗ | |
| GLAXOSMITHKLINE PLC | Exchange C | July 2, 2021 | July 6, 2021 | 4d | 12,979 | — | — | indirect | Form 4 ↗ | |
| GLAXOSMITHKLINE PLC | Exchange C | July 2, 2021 | July 6, 2021 | 4d | 1,505 | — | — | indirect | Form 4 ↗ |
Congressional trades
No member of Congress has disclosed a trade in this ticker in the filings we have parsed.
Related stocks
Tickers traded by the same people who traded CVRX, by number of filers in common. It shows overlap in public filings and nothing else.
- WVE Wave Life Sciences, Inc. 1 filer in common
- BCYC BICYCLE THERAPEUTICS PLC 1 filer in common
- INVA Innoviva, Inc. 1 filer in common
- LYEL Lyell Immunopharma, Inc. 1 filer in common
- DBTX Decibel Therapeutics, Inc. 1 filer in common
- GNCA GENOCEA BIOSCIENCES, INC. 1 filer in common
- TBPH Theravance Biopharma, Inc. 1 filer in common
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Form 4 transaction codes P = purchase. S = sale. These are the two market trades.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- What disclosure data cannot tell you Filings are late by design: up to 45 days for Congress, two business days for insiders.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| SEC EDGAR, Form 4 | 23 | 56 | July 6, 2021 | August 13, 2026 | Form 4 list on EDGAR |
Site built October 22, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Insider rows are Form 4 filings for this issuer from SEC EDGAR; congressional rows are periodic transaction reports parsed from the House Clerk and the Senate eFD. Values use the reported price for Form 4 and the disclosed range for Congress. See methodology and corrections.
Not investment advice. Disclosures are shown as filed and may lag the trade or be amended. No recommendation is made or implied.